Cellectis S.A. Files Form 6-K
Ticker: CLLS · Form: 6-K · Filed: Nov 19, 2025 · CIK: 1627281
| Field | Detail |
|---|---|
| Company | Cellectis S.A. (CLLS) |
| Form Type | 6-K |
| Filed Date | Nov 19, 2025 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, foreign-private-issuer, regulatory-update
TL;DR
Cellectis S.A. filed a standard 6-K report with the SEC on Nov 19, 2025.
AI Summary
Cellectis S.A. filed a Form 6-K on November 19, 2025, reporting as a foreign private issuer. The filing indicates that the company is submitting its report under Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934. Cellectis S.A. is incorporated in France and its fiscal year ends on December 31.
Why It Matters
This filing is a routine report for foreign private issuers, providing an update on the company's regulatory disclosures to the SEC.
Risk Assessment
Risk Level: low — This filing is a routine administrative report and does not contain new financial or operational information that would typically impact risk.
Key Players & Entities
- Cellectis S.A. (company) — Registrant
- 001-36891 (company) — Commission File Number
- November 2025 (date) — Reporting Period
- 1934 (date) — Securities Exchange Act Year
- 8, rue de la Croix Jarry (location) — Principal Executive Office Address
- Paris, France (location) — Principal Executive Office Location
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers required to be filed pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, providing information that the registrant makes or is required to make public pursuant to the laws of its home country, or is required to file with or submit to any stock exchange on which it has securities listed, or is made or is required to make public by its security holders.
When was this specific Form 6-K filed?
This Form 6-K was filed on November 19, 2025.
What is the company's primary business classification?
Cellectis S.A. is classified under Standard Industrial Classification code 2836, which pertains to Biological Products (No Diagnostic Substances).
Where is Cellectis S.A. headquartered?
Cellectis S.A.'s principal executive office is located at 8, rue de la Croix Jarry, 75013 Paris, France.
Does Cellectis S.A. file annual reports under Form 20-F?
Yes, the filing indicates with a checkmark that Cellectis S.A. files annual reports under cover of Form 20-F.
Filing Stats: 157 words · 1 min read · ~1 pages · Grade level 9.8 · Accepted 2025-11-19 06:35:03
Filing Documents
- f6k_111925.htm (6-K) — 6KB
- exh_991.htm (EX-99.1) — 7KB
- 0001171843-25-007423.txt ( ) — 14KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Cellectis S.A. (Registrant) Date: November 19, 2025 /s/ Andr Choulika Andr Choulika Chief Executive Officer